News

NEW: Rules for compound accumulation in P. aeruginosa published in Nature.    

UIUC Press Release Team discovers rules for breaking into Pseudomonas Researchers report in the journal Nature that they have found ...
Read More
Prof. David Shapiro and Prof. Paul Hergenrother

NEW: A compound from the Hergenrother/Shapiro collaboration has been licensed and is advancing toward treatment of breast cancer.

Unprecedented Compound Takes a Step Toward Breast Cancer Clinical Trials Estrogen receptor-positive breast cancer is the most common form of ...
Read More

Watch the Big Ten Network documentary on the UIUC COVID saliva test, featuring Dr. Diana Ranoa!

Summary from YouTube: In 2020, the U.S. was in the grips of the COVID-19 pandemic without any vaccines in sight ...
Read More

Postdoctoral Positions Open in the Hergenrother Lab

There are multiple postdoctoral positions open in the Hergenrother lab, for talented scientists with expertise/interest in either chemistry or biology ...
Read More

Read Young Innovator profile on Dr. Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19.

Young Innovator Program Inventor Spotlight: Diana Ranoa, describing her pivotal role in developing the UIUC saliva test for COVID-19. Diana ...
Read More

Congratulations to graduate student Matthew Boudreau for being awarded a prestigious fellowship from NCI!

Matthew Boudreau, a chemistry PhD candidate in the CCIL Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant ...
Read More
Head shot of Prof. Paul Hergenrother

A compound for breast cancer discovered and developed in the Hergenrother and Shapiro labs has been licensed to Bayer

Paul Hergenrother helps discover cancer compound now in licensing deal. Researchers affiliated with the Cancer Center at Illinois discovered a ...
Read More

Congratulations to Riley Svec

Riley Svec was awarded a position on the NIH Chemistry-Biology Interface Training Grant. He was an Advanced Graduate Student speaker ...
Read More

Congratulations to Kristen Muñoz for being awarded a position on the NIH Chemistry-Biology Interface Training Grant!

Gram-negative bacteria have emerged that are resistant to most antibiotics, a troubling trend since a new class of antibiotics for ...
Read More

Congratulations to two students for receiving NSF Research Fellowships

We congratulate graduate student Martin Garcia Chavez and undergraduate Amanda Cowfer for being awarded NSF Research Fellowships! ...
Read More

See story on Pretzel, a pet dog with glioma successfully treated with PAC-1.

Clinical trials on companion animals diagnosed with cancer have brought new hope to their owners—and new data for a cutting-edge ...
Read More
PAC-1

A Phase 1b clinical trial of PAC-1 for glioblastoma patients has begun

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with ...
Read More

eNTRyway is LIVE!

eNTRyway is our web app for predicting compound accumulation in Gram-negative bacteria. It predicts the likelihood of a small-molecule to ...
Read More